Skip to main content

Share story

Science

Quantum spin resonance in engineered proteins for multimodal sensing

Scientists have engineered a class of magneto-sensitive fluorescent proteins, including MagLOV, that exhibit optically detected magnetic resonance in living bacterial cells at room temperature. The proteins were derived from the LOV2 domain and further modified through directed evolution to alter their responses to magnetic fields and radio frequencies. The effects arise from a spin-correlated radical-pair mechanism involving the protein backbone and a bound flavin cofactor. The resonance produces a signal-to-noise ratio high enough for single-cell detection on a standard wide-field fluorescence microscope. Both magnetic field effects and optically detected magnetic resonance signals can be measured through changes in fluorescence emission. The proteins can be expressed directly in host organisms and their performance adjusted through genetic methods such as rational design or directed evolution. Researchers applied gradient magnetic fields to localize the depth position of multiple bands of bacterial cells embedded in a three-dimensional volume. The magnetic field effects were attenuated by magnetic resonance imaging contrast agents in a dose-dependent manner consistent with spin relaxation. Variants with differing dynamic responses were generated to support signal multiplexing and lock-in detection in noisy measurement environments. The work shows that the proteins can serve as reporters for spatial imaging, microenvironment sensing, and mitigation of light scattering and autofluorescence in biological samples.
Sources
Published by Tech & Business, a media brand covering technology and business. This story was sourced from Nature and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital
Capital

Nominal raises $240 million at a $3 billion valuation

Nominal has raised $240 million at a $3 billion valuation, triple its valuation in a funding round earlier this year, Bloomberg reports. The startup builds software to make manufacturing more efficient.

Capital Products
Capital Products

Onodrim raises $300M to acquire European defence and industrial suppliers

Amsterdam-based Onodrim Industries has raised $300M in a round led by Lux Capital, valuing the defence group at $1.3bn, the company said Monday. Other investors include General Catalyst, Lakestar and Altimeter. The financing follows its €40M seed round in February.

Capital
Capital

SRTD Biotech raises €31.5 million for targeted RNA therapies

SRTD Biotech has completed an oversubscribed €31.5 million seed financing to develop RNA therapies designed to act selectively inside diseased cells. Mérieux Equity Partners led the round, with NRW.BANK and Boehringer Ingelheim Venture Fund joining as co-leads.